ANZ Banking Group (ANZ)

Size: px
Start display at page:

Download "ANZ Banking Group (ANZ)"

Transcription

1 1 May 2018 Analyst TS Lim Authorisation Chris Savage Recommendation Buy (unchanged) Price $27.47 Target (12 months) $30.20 (unchanged) GICS Sector Banks Expected Return Capital growth 9.9% Dividend yield 5.9% Total expected return 15.8% Company Data & Ratios Enterprise value Market cap n/m $79,629m Issued capital 2,899m Free float 100% Avg. daily val. (52wk) $198.1m 12 month price range $ $32.95 Price Performance (1m) (3m) (12m) Price (A$) Absolute (%) Rel market (%) ANZ Banking Group (ANZ) Unveiling some universal truths in anxious times ~$3.5bn cash NPAT (continuing), 80cps interim dividend ANZ s 1H18 result components are: (1) reported NPAT $3,323m (BP $2,818m); (2) cash NPAT $2,876m (BP $2,733m); (3) cash EPS 98cps (BP 93cps); (4) cash NPAT (continuing) $3,493m (BP $3,295m); (5) cash EPS (continuing) 119cps (BP 112cps); (6) fully franked interim dividend 80cps (BP 81cps), cash payout ratio 80% (BP 87%), continuing payout ratio 66% (BP 73%) DRP to be neutralised; (7) cash ROE 9.8% (BP 9.3%), continuing 11.9% (BP 11.2%); (8) Group NIM 1.93% (BP 1.99%); (9) credit impairment charge $408m/15bp GLA (BP $497m/17bp); (10) cost to income ratio (continuing) 45% (BP 46%); and (11) CET1 capital ratio 11.0% (BP 10.8%). On an underlying basis, most metrics were better than expected with the exception of Group NIM and a flat interim dividend. The NIM outcome took us by surprise, -7bp pcp and -5bp hoh to 1.93% mainly due to unfavourable Markets activities including liquidity drag. Excluding the Markets impact and the removal of Asia Retail & Wealth NIE, NIM would have been only 1bp lower to 1.99% and 1.97% respectively. The fact that underlying NIM was relatively stable appears to be a share price support factor today. While the market may have expected a higher interim dividend, we believe this does not appear to be a major concern given ANZ s very strong CET1 ratio of 11.0% (~11.8% pro-forma, and with 146bp additional upside from further asset sales, e.g. AMMB Holdings and PT Bank Pan Indonesia). Be that as it may, the current CET1 ratio already exceeds APRA s 10.5% minimum requirement by 2020 and this suggests further capital initiatives to come (share buyback still favoured as we understand). $30.20 price target and Buy rating maintained We have only adjusted 2018 cash NPAT on a continuing basis by +4% to reflect the differences in other income and credit impairment charge as per our variance analysis. With subsequent years estimates remaining unchanged, we have maintained ANZ s $30.20 price target. Based on a forward 12-month TSR of >15% and ANZ s enhanced capital management flexibility, the Buy rating is also maintained. Absolute Price $34 $32 $30 $28 $26 $24 $22 $20 May Sep ANZ Jan 17 May Sep Jan S&P 300 Rebased Earnings Forecast Year end 30 September (continuing operations) e 2019e 2020e NPAT (reported) (A$m) 6,406 6,537 6,836 7,127 NPAT (cash) (A$m) 6,809 6,861 6,896 7,187 EPS (cash) (A ) EPS (cash) growth (%) 15% 1% 1% 4% PER (x) P/Book (x) P/NTA (x) Dividend (A ) Yield (%) 5.8% 5.9% 6.0% 6.2% ROE (%) 11.7% 11.6% 10.9% 10.8% NIM (%) 1.99% 1.91% 1.87% 1.87% Franking (%) 100.0% 100.0% 100.0% 100.0% SOURCE: IRESS SOURCE: BELL POTTER SECURITIES ESTIMATES BELL POTTER SECURITIES LIMITED ABN AFSL DISCLAIMER: THIS REPORT MUST BE READ WITH THE DISCLAIMER ON PAGE 12 THAT FORMS PART OF IT. Page 1

2 Unveiling some universal truths in anxious times ~$3.5bn cash NPAT (continuing), 80cps interim dividend ANZ s 1H18 result components are: 1. Reported NPAT $3,323m (BP $2,818m); 2. Cash NPAT $2,876m (BP $2,733m); 3. Cash EPS 98cps (BP 93cps); 4. Cash NPAT (continuing) $3,493m (BP $3,295m); 5. Cash EPS (continuing) 119cps (BP 112cps); 6. Fully franked interim dividend 80cps (BP 81cps), cash payout ratio 80% (BP 87%), continuing payout ratio 66% (BP 73%); 7. Cash ROE 9.8% (BP 9.3%), continuing 11.9% (BP 11.2%); 8. Group NIM 1.93% (BP 1.99%); 9. Credit impairment charge $408m/15bp GLA (BP $497m/17bp); 10. Cost to income ratio (continuing) 45% (BP 46%); and 11. CET1 capital ratio 11.0% (BP 10.8%). As foreshadowed in our preview note, there was a lot of noise in today s result and ANZ continues to report three versions of NPAT: (a) statutory (i.e. reported) NPAT including discontinued operations; (b) cash NPAT including discontinued operations (statutory NPAT adjusted for economic and revenue hedges, treasury shares, etc.); and (c) cash NPAT from continuing operations (including gain or loss on sale from divestments and divested business results Asia Retail, Shanghai Rural Commercial Bank and Metrobank Card Corporation). Heading into 2H18 and based on residual noise from announced asset sales, the third version of NPAT will remain relevant in assessing the bank s underlying (i.e. continuing operations) performance. Figure 1 Noisy 1H18 but as expected Page 2

3 On an underlying basis, most metrics were then better than expected with the exception of Group NIM and a flat interim dividend. The NIM outcome took us by surprise, -7bp pcp and -5bp hoh to 1.93% mainly due to unfavourable Markets Balance Sheet activities including ongoing liquidity drag from having excess liquidity on the balance sheet. Excluding the Markets impact and the removal of Asia Retail & Wealth NIE, NIM would have been only 1bp lower to 1.99% and 1.97% respectively. The fact that underlying NIM was relatively stable appears to be a key support factor for today s share price. While the market may have expected a higher interim dividend, we believe this does not appear to be a major concern given ANZ s very strong CET1 ratio of 11.0% (~11.8% proforma including ~85bp capital benefit from announced divestments net of ~40bp impact of $1.5bn share buyback program, 16.3% international and comfortably ahead of the 14.7% global top quartile benchmark). This would materially exceed APRA s 10.5% minimum requirement by 2020 that would also suggest further capital initiatives to come (share buyback still favoured as we understand). Leverage ratio was 5.4% (6.1% international), roughly unchanged since 1Q18. Organic capital generation was also strong at +72bp (vs. +118bp in 2017) and allocation has become more efficient with more than half of regulatory capital now allocated to the higher ROE retail and commercial businesses upside risk to long term ROE. Figure 2 Top quartile in global CET1 Figure 3 Capital efficiency on the rise, helps long term ROE Page 3

4 The 80cps interim dividend is fully franked (franking credits tight but manageable according to management) and represents a 66% payout ratio on a cash continuing basis (in line with the 60-65% target). The DRP will be neutralised by acquiring shares on the market and further capital initiatives will be considered after taking into account business conditions, regulatory approvals and requirements to support business growth. All else being equal, we reiterate that ANZ s CET1 ratio would further benefit from the inevitable sale of investments in AMMB Holdings (24% stake, $1,185m carrying value or ~30bp benefit) and PT Bank Pan Indonesia (39% stake, $1,033m carrying value or ~26bp benefit) that would increase the ~11.8% pro-forma CET1 ratio by ~146bp and further strengthen the bank s capital management flexibility. Finally, ANZ s existing capital deduction should also sufficiently cover the impact of IFRS 9 (the requirement to recognise expected credit impairment charges earlier) and all funding metrics remain in good shape (NSFR 114.9% vs % at the end of 2017, LCR stable at 134% that is a good thing as too much liquidity drags on NIE/NIM). Top line growth on a continuing basis was flat no surprises here but ANZ s redeeming feature was, in our view, its solid underlying performance (that was helped by strong cost management that resulted in neutral pcp Jaws +2% hoh Jaws ) and steady improvements in CET1 capital and underlying ROA and ROE. Table 1 Strong underlying KPIs likely supported today s share price performance In terms of credit quality, the market traditionally takes a dim view of any lower credit impairment charge to boost the bottom line. In ANZ s case, there appears to be an exception today given the lower charge was consistent with decreases in new and existing provisions across ALL divisions: Australia division benefited from lower provisions and higher write-backs; Institutional division benefited from lower provisions from ongoing portfolio rebalancing; New Zealand division benefited from lower provisions and a one-off large provision taken in the previous year; and Asia Retail & Pacific benefited from the sale of Asia Retail and Wealth businesses. Page 4

5 The positive experience also gels with lower GIA (across all divisions and exposure size; $2,034m vs. $2,384m in 2H17 and $2,940m in 1H17), lower new impaired assets [across all divisions ($963m vs. $1,425m in 2H17 and $1,787m in 1H17) and particularly in impaired loans ($917m vs. $1,315m in 2H17 and $1,637m in 1H17) and non-performing commitments and contingencies ($25m vs. $89m in 2H17 and $62m in 1H17) and with restructured items stable at $21m]. Figure 4 Credit quality still improving 1 Figure 5 Credit quality still improving 2 Variance analysis is disclosed in Table 2 on the next page. Page 5

6 Table 2 Numbers broadly in line with our expectations ANZ Banking Group Y/e September 30 ($m) 1H18 BP Variance Comments Net interest income 7,350 7,399-1% Broadly in line with our expectations Other operating income 2,458 2,185 12% Variance due to timing differences in Wealth income Operating income 9,808 9,584 2% Variance largely due to timing differences in Wealth income Operating expenses -4,411-4,394 0% Broadly in line with our expectations Credit impairment charge % Lower charge across all divisions reflecting lower new and existing provisions Profit before income tax 4,989 4,694 6% Variance largely due to timing differences in Wealth income and lower credit charge Income tax expense -1,489-1,391-7% Function of profit before income tax Non-controlling interests -7-7 n/m Broadly in line with our expectations NPAT (cash basis, continuing) 3,493 3,295 6% Variance largely due to timing differences in Wealth income and lower credit charge Discontinued operations n/m Variance largely reflects lower operating income from discontinued operations NPAT (cash basis) 2,876 2,733 5% Variance largely due to timing differences in Wealth income and lower credit charge DPS (cps) % Unchanged pcp EPS (cash basis, continuing) (cps) % Variance largely due to timing differences in Wealth income and lower credit charge NIM 1.93% 1.99% -0.06% Largely impacted by lower Markets earnings and liquidity drag ROE (cash basis, continuing) 11.9% 9.3% 2.7% Variance largely due to timing differences in Wealth income and lower credit charge Outlook Management has decided to play the conservative card in terms of the outlook over the next 6-12 months, citing revenue constraints (general slowdown in housing approvals including the need for tighter procedures arising from the Royal Commission that would also slow down the approval process), greater competition from smaller banks and nonbanks, consumer cautiousness and residual NIM headwinds (perhaps by a few bp). However, credit conditions should remain benign (providing the unemployment rate continues to be manageable) and ANZ in our view will still retain the capacity to push the cost lever and focus on profitable growth. Figure 6 Outlook conservative Page 6

7 $30.20 price target and Buy rating maintained We have only adjusted 2018 cash NPAT on a continuing basis by +4% to reflect the differences in other income and credit impairment charge as per our variance analysis in the above table. With subsequent years estimates remaining unchanged (Table 3, next page), we have maintained ANZ s $30.20 price target (Table 4, next page). Based on a forward 12-month TSR of >15% and ANZ s enhanced capital management flexibility, the Buy rating is also maintained. Table 3 Estimate changes ANZ Bank 2018e 2019e 2020e 2021e Y/e September 30 ($m) Current Previous Change Current Previous Change Current Previous Change Current Previous Change Profit & Loss Net interest income 14,656 14,925-2% 14,935 15,489-4% 15,618 16,158-3% 16,355 16,895-3% Other operating income 4,782 4,419 8% 4,730 4,465 6% 4,931 4,564 8% 5,056 4,678 8% Operating income 19,439 19,343 0% 19,665 19,954-1% 20,549 20,722-1% 21,412 21,573-1% Operating expenses -8,804-8,883 1% -8,821-9,031 2% -9,102-9,203 1% -9,440-9,610 2% Credit impairment charge ,070 27% -1,025-1,169 14% -1,211-1,280 6% -1,351-1,369 1% Profit before income tax 9,793 9,390 4% 9,819 9,755 1% 10,236 10,239 0% 10,620 10,594 0% Income tax expense -2,918-2,783-5% -2,909-2,843-2% -3,035-2,983-2% -3,149-3,086-2% Non-controlling interests n/m n/m n/m n/m NPAT (cash basis) 6,120 6,100 0% 6,896 6,898 0% 7,187 7,241-1% 7,457 7,494 0% NPAT (cash basis, continuing) 6,861 6,592 4% 6,896 6,898 0% 7,187 7,241-1% 7,457 7,494 0% DPS (cps) % % % % EPS (cash basis, continuing) (cps) % % % % ROE (cash basis, continuing) 11.6% 10.3% 1.3% 10.9% 11.1% -0.1% 10.8% 11.1% -0.2% 10.8% 11.0% -0.2% NIM 1.91% 1.99% -0.08% 1.87% 1.98% -0.11% 1.87% 1.97% -0.10% 1.87% 1.96% -0.09% Cost ratio (continuing) 45% 46% 1% 45% 45% 0% 44% 44% 0% 44% 45% 0% Impairment expense as % of GLA 0.14% 0.18% 0.04% 0.16% 0.18% 0.02% 0.18% 0.19% 0.01% 0.20% 0.20% 0.00% Effective tax rate 30% 30% 0% 30% 29% 0% 30% 29% -1% 30% 29% -1% Table 4 Composite valuation Composite Valuation Value ($m) Per share Weighting Composite value per share DCF 83,653 $ % $7.21 Dividend yield (sustainable) 72,692 $ % $6.27 ROE (sustainable) 82,236 $ % $7.09 Sum-of-Parts 94,514 $ % $8.15 Total $28.73 Total plus notional surplus capital $1.47 $30.20 Table 5 SOP valuation Sum-of-Parts (As Is) 2019e NPAT Pros. PE (times) Value ($m) Per share Australia 3, ,480 $19.14 Asia Retail & Pacific 15-0 $0.00 Institutional 1, ,392 $7.38 Wealth Australia 98-0 $0.00 New Zealand 1, ,764 $6.82 Other ,121 -$0.73 Total 6, ,514 $32.61 Page 7

8 Key segment 6-month trends Table 6 Group Group KPIs 1H11 2H11 1H12 2H12 1H13 2H13 1H14 2H14 1H15 2H15 1H16 2H16 1H17 2H17 1H18 Growth in NIE 8% 4% 6% 5% 4% 7% 8% 8% 6% 3% 6% 4% -2% -1% -1% Growth in other income 22% -1% -2% 18% 4% -8% 2% 4% 5% -2% -12% 2% -5% -17% -4% Growth in operating expenses 18% 5% 8% 13% -2% -4% 6% 6% 7% 5% 4% 2% -6% -7% -2% Growth in PBT before BDD 8% 0% 0% 6% 10% 7% 7% 7% 4% -2% -3% 5% 1% -4% -2% Growth in loans 13% 13% 9% 8% 10% 13% 12% 8% 9% 9% 1% 1% 3% 1% 3% Growth in deposits 5% 23% 16% 6% 14% 10% 11% 15% 0% -6% 6% 6% 7% 4% 0% NIM 2.46% 2.45% 2.35% 2.28% 2.24% 2.19% 2.15% 2.13% 2.04% 2.04% 2.07% 2.06% 2.00% 1.98% 1.93% Cost ratio 45% 46% 47% 48% 44% 45% 44% 45% 45% 47% 47% 46% 45% 46% 45% Cost / average assets 1.43% 1.37% 1.36% 1.40% 1.23% 1.23% 1.19% 1.19% 1.13% 1.07% 1.07% 1.06% 0.99% 1.00% 0.96% Tier 1 capital ratio 10.5% 10.9% 11.3% 10.8% 9.8% 10.4% 10.3% 10.7% 10.6% 11.3% 11.6% 11.8% 12.1% 12.6% 12.9% Impairment expense / RWA 0.50% 0.39% 0.40% 0.46% 0.37% 0.35% 0.29% 0.26% 0.26% 0.28% 0.47% 0.50% 0.36% 0.24% 0.21% Total provisions + GRCL / RWA 1.95% 1.84% 1.73% 1.59% 1.41% 1.28% 1.20% 1.09% 1.04% 1.00% 1.06% 1.02% 1.02% 0.97% 0.91% ROE 16.1% 15.2% 15.5% 14.7% 15.5% 15.1% 15.5% 15.3% 14.7% 12.9% 9.7% 10.9% 11.6% 11.8% 11.9% Table 7 Australia Australia 1H11 2H11 1H12 2H12 1H13 2H13 1H14 2H14 1H15 2H15 1H16 2H16 1H17 2H17 1H18 Market share - Loans 11.2% 11.2% 11.9% 12.0% 12.2% 12.4% 12.4% 12.5% 12.5% 12.8% 12.7% 12.6% 12.2% 12.1% 12.1% - Deposits 9.1% 9.2% 9.3% 9.5% 9.5% 9.7% 9.5% 9.4% 9.2% 9.8% 9.9% 9.8% 9.9% 9.8% 9.7% NIM 2.60% 2.56% 2.45% 2.50% 2.53% 2.51% 2.50% 2.54% 2.54% 2.55% 2.75% 2.74% 2.73% 2.73% 2.78% Other income / footings 0.35% 0.00% 0.15% 0.15% 0.14% 0.14% 0.13% 0.12% 0.13% 0.13% 0.12% 0.12% 0.12% 0.11% 0.10% Operating expense / footings 0.51% 0.30% 0.39% 0.38% 0.36% 0.35% 0.34% 0.34% 0.34% 0.33% 0.34% 0.34% 0.32% 0.32% 0.33% Cost ratio 43% 37% 42% 40% 38% 37% 37% 37% 36% 36% 36% 37% 36% 36% 37% Impairment expense / loans 0.18% 0.13% 0.11% 0.15% 0.15% 0.16% 0.14% 0.14% 0.13% 0.15% 0.14% 0.14% 0.14% 0.13% 0.09% Effective tax rate 30% 30% 30% 30% 30% 30% 30% 30% 30% 30% 30% 30% 30% 30% 30% Table 8 Institutional Institutional 1H11 2H11 1H12 2H12 1H13 2H13 1H14 2H14 1H15 2H15 1H16 2H16 1H17 2H17 1H18 Market share - Loans 4.2% 3.0% 2.5% 2.4% 2.5% 2.5% 2.6% 2.9% 6.1% 5.8% 4.9% 4.8% 4.9% 4.8% 4.9% - Other IEA 5.2% 8.0% 7.4% 7.9% 8.0% 7.9% 8.0% 8.7% 10.2% 10.6% 10.9% 10.8% 9.6% 9.3% 10.0% - IBL 8.1% 11.8% 9.5% 9.8% 9.8% 10.1% 10.3% 11.7% 13.3% 12.4% 12.0% 11.9% 12.2% 12.0% 12.2% NIM 1.31% 1.32% 1.12% 1.06% 0.99% 1.01% 0.98% 0.91% 1.19% 1.21% 1.15% 1.11% 1.08% 0.99% 0.91% Other income / footings 0.24% 0.12% 0.20% 0.16% 0.18% 0.14% 0.15% 0.12% 0.20% 0.15% 0.15% 0.13% 0.22% 0.16% 0.15% Operating expense / footings 0.22% 0.17% 0.20% 0.23% 0.17% 0.16% 0.16% 0.13% 0.22% 0.23% 0.24% 0.23% 0.22% 0.22% 0.20% Cost ratio 35% 37% 35% 49% 35% 37% 38% 35% 47% 51% 56% 59% 47% 54% 54% Impairment expense / loans 0.07% 0.02% 0.08% 0.08% 0.04% 0.02% 0.03% 0.00% 0.02% 0.03% 0.08% 0.10% 0.03% -0.01% 0.01% Effective tax rate 29% 33% 32% 37% 31% 31% 32% 28% 28% 29% 28% 32% 29% 30% 29% Table 9 New Zealand New Zealand 1H11 2H11 1H12 2H12 1H13 2H13 1H14 2H14 1H15 2H15 1H16 2H16 1H17 2H17 1H18 Growth - Loans -7.6% -11.0% -3.3% 3.0% 4.6% 4.1% 5.3% 5.4% 5.7% 8.5% 10.6% 8.0% 4.3% 3.6% 3.3% - Deposits -9.1% -15.4% -2.8% 9.0% 6.8% 3.5% 8.3% 11.7% 1.4% 3.2% 22.7% 16.2% 7.8% 7.2% 7.0% NIM 2.10% 2.46% 2.63% 2.57% 2.50% 2.49% 2.49% 2.49% 2.52% 2.57% 2.40% 2.35% 2.30% 2.31% 2.37% Other income / footings 0.13% 0.13% 0.13% 0.13% 0.12% 0.13% 0.11% 0.10% 0.10% 0.23% 0.08% 0.08% 0.07% 0.08% 0.08% Operating expense / footings 0.41% 0.34% 0.43% 0.43% 0.36% 0.34% 0.32% 0.31% 0.31% 0.36% 0.30% 0.31% 0.29% 0.28% 0.28% Cost ratio 50% 40% 50% 51% 45% 42% 41% 41% 40% 40% 39% 40% 38% 37% 36% Impairment expense / loans 0.11% 0.14% 0.12% 0.10% 0.04% 0.01% -0.04% 0.03% 0.02% 0.04% 0.04% 0.07% 0.03% 0.04% 0.02% Effective tax rate 34% 26% 28% 27% 28% 27% 28% 28% 28% 27% 27% 28% 28% 28% 28% Page 8

9 ANZ Banking Group Company description ANZ operates primarily in Australia, New Zealand and selected markets in the Asia Pacific region via its Institutional Bank. The Group services 6m customers and provides the following products and services: retail banking; business banking and institutional banking. Investment strategy ANZ s focus is now on the more profitable and higher ROE Australian and New Zealand consumer and business banking space, although we believe there is still some value in selected offshore locations focusing on the institutional including trade finance and high net worth segments. Valuation The price target is closely aligned with the bank s composite valuation, weighted in the table below. Table 10 Composite valuation Composite Valuation Value ($m) Per share Weighting Composite value per share DCF 83,653 $ % $7.21 Dividend yield (sustainable) 72,692 $ % $6.27 ROE (sustainable) 82,236 $ % $7.09 Sum-of-Parts 94,514 $ % $8.15 Total $28.73 Total plus notional surplus capital $1.47 $30.20 Table 11 SOP valuation Sum-of-Parts (As Is) 2019e NPAT Pros. PE (times) Value ($m) Per share Australia 3, ,480 $19.14 Asia Retail & Pacific 15-0 $0.00 Institutional 1, ,392 $7.38 Wealth Australia 98-0 $0.00 New Zealand 1, ,764 $6.82 Other ,121 -$0.73 Total 6, ,514 $32.61 SWOT analysis Strengths 1. Domestic retail and SME banking franchise, including service and sales, and corporate banking; and 2. Management execution. Weaknesses 1. Underweight home lending Australia (although being addressed); and 2. Overweight New Zealand. Opportunities 1. Further cost management; and 2. Divesting non-core businesses (under way). Threats 1. Macroeconomic factors such as higher regulatory requirements, higher regional unemployment and slowing domestic credit growth; Page 9

10 2. Rising wholesale funding costs; 3. Sovereign risk exposed to sometimes unstable governments; and 4. Increased competition specifically from CBA, WBC and NAB on the domestic front in retail and wholesale banking and wealth management. Sensitivities Table 12 Sensitivities Y/e September e 2019e 2020e 2021e 2022e 2023e 2024e 2025e 2026e Sensitivities Group NIM +10bp NPAT upside (underlying basis) 7.8% 8.1% 8.1% 8.2% 8.3% 8.3% 8.4% 8.5% 8.5% - Price target upside $2.36 $2.45 $2.46 $2.48 $2.50 $2.52 $2.54 $2.56 $2.57 Group Loans +1% NPAT upside (underlying basis) 0.6% 0.6% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% - Price target upside $0.20 $0.20 $0.20 $0.20 $0.20 $0.20 $0.20 $0.20 $0.20 Aust. loans (ex Wealth/IB) +1% NPAT upside (underlying basis) 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% - Price target upside $0.17 $0.17 $0.18 $0.18 $0.18 $0.18 $0.19 $0.19 $0.19 APEA loans +1% NPAT upside (underlying basis) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% - Price target upside $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 NZ loans +1% NPAT upside (underlying basis) 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% - Price target upside $0.06 $0.06 $0.06 $0.06 $0.06 $0.06 $0.06 $0.06 $0.06 Other income +1% NPAT upside (underlying basis) 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% - Price target upside $0.15 $0.14 $0.15 $0.14 $0.14 $0.14 $0.14 $0.14 $0.14 BDD +1% NPAT upside (underlying basis) -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% - Price target upside -$0.03 -$0.03 -$0.04 -$0.04 -$0.04 -$0.04 -$0.04 -$0.04 -$0.04 Costs +1% NPAT upside (underlying basis) -0.9% -0.9% -0.9% -0.9% -0.9% -0.9% -0.9% -0.9% -0.9% - Price target upside -$0.27 -$0.27 -$0.27 -$0.27 -$0.27 -$0.27 -$0.27 -$0.28 -$0.28 Page 10

11 ANZ Banking Group as at 1 May 2018 Recommendation Buy Price $27.47 Target (12 months) $30.20 ANZ Banking Group (ANZ) 1 May 2018 Table 13 Financial summary ANZ Bank Share Price (A$) As at 1-May-18 Market Cap (A$M) 79,629 PROFIT AND LOSS VALUATION DATA Y/e September 30 ($m) e 2019e 2020e Y/e September e 2019e 2020e Net interest income 15,064 14,875 14,656 14,935 15,618 NPAT (cash basis, continuing) ($m) 6,488 6,809 6,861 6,896 7,187 Other banking income 4,058 4,327 4,183 4,118 4,302 EPS (statutory basis) (cps) Total banking income 19,122 19,202 18,839 19,053 19,920 - Growth -27% 11% 2% 5% 4% Funds management income EPS (cash basis, continuing) (cps) Insurance income Growth -22% 15% 1% 1% 4% Operating income 20,608 19,816 19,439 19,665 20,549 P / E ratio (times) Operating expenses -9,588-8,967-8,804-8,821-9,102 P / Book ratio (times) Credit impairment charge -1,933-1, ,025-1,211 P / NTA ratio (times) Profit before income tax 9,087 9,650 9,793 9,819 10,236 Net DPS (cps) Income tax expense -2,588-2,826-2,918-2,909-3,035 Yield 5.8% 5.8% 5.9% 6.0% 6.2% Non-controlling interests Franking 100% 100% 100% 100% 100% Investment experience Payout (cash basis, continuing) 79% 69% 69% 70% 70% NPAT (cash basis, continuing) 6,488 6,809 6,861 6,896 7,187 Discontinued operations CAPITAL ADEQUACY NPAT (cash basis) 5,889 6,938 6,120 6,896 7,187 Y/e September e 2019e 2020e Hedging, one off gains, etc Risk weighted assets ($m) 408, , , , ,810 NPAT (statutory basis) 5,709 6,406 6,537 6,836 7,127 Average risk weight 47% 47% 46% 49% 49% Tier 1 ratio 11.8% 12.6% 13.0% 13.3% 13.2% CASHFLOW CET1 capital ratio 9.6% 10.6% 11.2% 11.6% 11.6% Y/e September 30 ($m) e 2019e 2020e Total capital ratio 14.3% 14.8% 15.0% 15.1% 15.0% NPAT (cash basis) 5,889 6,938 6,120 6,896 7,187 Equity ratio 6.3% 6.6% 6.3% 6.6% 6.6% Increase in loans -6,459-4,441-24,960-25,701-29,259 DIVISIONAL Increase in other assets -24,394 40,415-19,918-12,755-13,532 Y/e September 30 ($m) e 2019e 2020e Capital expenditure Australia Investing cashflow -30,837 36,214-44,834-38,514-42,850 Net interest income 8,202 8,218 8,640 8,925 9,409 Other income 1,206 1,217 1,134 1,195 1,259 Increase in deposits & borrowings 28,550 22,327 19,960 31,739 35,882 Total banking income 9,408 9,435 9,774 10,120 10,668 Increase in other liabilities -4,155-41,018 35,884 1,441 4,348 Operating expenses -3,426-3,382-3,601-3,660-3,796 Ordinary equity raised Impairment expenses Other -4,675-5,088-3,107-1,563-4,568 Net profit before tax 5,062 5,168 5,505 5,668 5,965 Financing cashflow 19,720-23,779 52,736 31,618 35,663 Corporate tax expense -1,515-1,552-1,656-1,705-1,794 NPAT (cash basis, continuing) 3,547 3,616 3,849 3,963 4,170 Net change in cash -5,228 19,373 14, Loans 327, , , , ,536 Cash at end of period 48,675 68,048 82,071 82,071 82,071 Deposits 187, , , , ,245 BALANCE SHEET Asia Retail & Pacific Y/e September 30 ($m) e 2019e 2020e Net interest income Cash and liquid assets 48,675 68,048 82,071 82,071 82,071 Other income Divisional gross loans 577, , , , ,971 Total banking income 1, Provisions -4,183-3,798-3,673-3,977-4,168 Operating expenses Other gross loans / inter div. 1, ,370 3,370 3,370 Impairment expenses Other IEA 234, , , , ,728 Net profit before tax Intangibles 7,672 6,970 5,338 5,338 5,338 Corporate tax expense PP&E 2,205 1,965 1,920 1,978 2,038 NPAT (cash basis, continuing) Insurance assets 35,656 37, Loans 13,370 5,503 1, Other assets 11,082 11,113 51,567 51,567 51,567 Deposits 22,782 9,157 1, Total assets 914, , , ,064 1,035,914 Institutional Divisional deposits & IBL 535, , , , ,978 Net interest income 3,447 3,264 3,020 3,127 3,277 Other borrowings 271, , , , ,347 Other income 1,733 2,366 2,084 2,189 2,300 Other liabilities 49,967 51,889 9,181 9,181 9,181 Total banking income 5,180 5,630 5,104 5,317 5,577 Total liabilities 856, , , , ,506 Operating expenses -2,958-2,814-2,779-2,920-3,034 Impairment expenses Ordinary share capital 28,765 29,088 27,943 28,321 28,713 Net profit before tax 1,479 2,724 2,233 2,264 2,358 Other equity instruments Corporate tax expense Reserves 1, NPAT (cash basis, continuing) 1,041 1,924 1,569 1,585 1,650 Retained profits 27,975 29,834 31,846 36,801 39,028 Loans 125, , , , ,730 Minority interests Other IEA 281, , , , ,420 Total shareholders' equity 57,927 59,075 60,456 65,789 68,408 IBL 227, , , , ,338 Total sh. equity & liabs. 914, , , ,064 1,035,914 Wealth Australia Net interest income WANOS - statutory (m) 2,892 2,910 2,904 2,903 2,916 Other operating income WANOS - underlying (m) 2,907 2,926 2,920 2,918 2,932 Net funds management income Net insurance & other income PROFITABILITY RATIOS Total operating income 1, Y/e September e 2019e 2020e Operating expenses Return on assets (cash, continuing) 0.7% 0.8% 0.7% 0.7% 0.7% Impairment expenses Return on equity (cash, continuing) 10.3% 11.7% 11.6% 10.9% 10.8% Net profit before tax Leverage ratio 5.3% 5.5% 5.6% 6.0% 6.0% Corporate tax expense Net interest margin (continuing) 2.07% 1.99% 1.91% 1.87% 1.87% NPAT (cash basis, continuing) Cost / income ratio (continuing) 47% 45% 45% 45% 44% FUM 48, Cost / average assets (continuing) 1.06% 1.00% 0.93% 0.90% 0.89% Growth in operating income 2% -4% -2% 1% 4% New Zealand Growth in operating expenses 3% -6% -2% 0% 3% Net interest income 2,448 2,519 2,545 2,573 2,655 Jaws (continuing) -1% 3% 0% 1% 1% Other income Effective tax rate 28% 29% 30% 30% 30% Total operating income 3,092 3,172 3,220 3,266 3,374 Operating expenses -1,225-1,193-1,177-1,216-1,237 ASSET QUALITY Impairment expenses Y/e September e 2019e 2020e Net profit before tax 1,747 1,901 1,990 1,961 2,022 Impairment expense / GLA 0.33% 0.21% 0.14% 0.16% 0.18% Corporate tax expense Impairment expense / RWA 0.47% 0.31% 0.21% 0.23% 0.26% Minority interests Total provisions ($m) 4,183 3,798 3,673 3,977 4,168 Investment experience Total provisions / RWA 1.02% 0.97% 0.91% 0.89% 0.89% NPAT (cash basis, continuing) 1,268 1,369 1,433 1,412 1,456 Indiv ass prov / gross imp assets 41% 48% 50% 50% 50% Loans 106, , , , ,451 IBL / IEA 100% 102% 109% 108% 107% Deposits 71,857 76,339 77,620 82,084 87,988 Total provisions + GRCL / RWA 1.02% 0.97% 0.91% 0.89% 0.89% Other IBL 25,268 24,262 23,650 23,332 23,332 SOURCE: BELL POTTER SECURITIES ESTIMATES Page 11

12 Recommendation structure Buy: Expect >15% total return on a 12 month view. For stocks regarded as Speculative a return of >30% is expected. Research Team Staff Member TS Lim Industrials Sam Haddad Chris Savage Title/Sector Head of Research Industrials Industrials Phone tslim shaddad csavage Hold: Expect total return between -5% Jonathan Snape Industrials jsnape and 15% on a 12 month view Tim Piper Industrials tpiper Sell: Expect <-5% total return on a 12 month view John Hester Tanushree Jain Financials Healthcare Healthcare/Biotech jhester tnjain Speculative Investments are either start-up enterprises with nil or only prospective operations or recently commenced operations with only forecast cash flows, or companies that have commenced operations or have been in operation for some time but have only forecast cash flows and/or a stressed balance sheet. TS Lim Lafitani Sotiriou Resources Peter Arden David Coates Analysts James Filius Alex McLean Banks/Regionals Diversified Resources Resources Analyst Analyst tslim lsotiriou parden dcoates jfilius amclean Such investments may carry an exceptionally high level of capital risk and volatility of returns. Bell Potter Securities Limited ACN Level 38, Aurora Place 88 Phillip Street, Sydney 2000 Telephone The following may affect your legal rights: DISCLAIMER This document is a private communication to clients and is not intended for public circulation or for the use of any third party, without the prior approval of Bell Potter Securities Limited. In the USA and the UK this research is only for institutional investors. It is not for release, publication or distribution in whole or in part to any persons in the two specified countries. In Hong Kong this research is being distributed by Bell Potter Securities (HK) Limited which is licensed and regulated by the Securities and Futures Commission, Hong Kong. This is general investment advice only and does not constitute personal advice to any person. Because this document has been prepared without consideration of any specific client s financial situation, particular needs and investment objectives ( relevant personal circumstances ), a Bell Potter Securities Limited investment adviser (or the financial services licensee, or the representative of such licensee, who has provided you with this report by arrangement with Bell Potter Securities Limited) should be made aware of your relevant personal circumstances and consulted before any investment decision is made on the basis of this document. While this document is based on information from sources which are considered reliable, Bell Potter Securities Limited has not verified independently the information contained in the document and Bell Potter Securities Limited and its directors, employees and consultants do not represent, warrant or guarantee, expressly or impliedly, that the information contained in this document is complete or accurate. Nor does Bell Potter Securities Limited accept any responsibility for updating any advice, views opinions, or recommendations contained in this document or for correcting any error or omission which may become apparent after the document has been issued. Except insofar as liability under any statute cannot be excluded. Bell Potter Securities Limited and its directors, employees and consultants do not accept any liability (whether arising in contract, in tort or negligence or otherwise) for any error or omission in this document or for any resulting loss or damage (whether direct, indirect, consequential or otherwise) suffered by the recipient of this document or any other person. DISCLOSURE Bell Potter Securities Limited, its employees, consultants and its associates within the meaning of Chapter 7 of the Corporations Law may receive commissions, underwriting and management fees from transactions involving securities referred to in this document (which its representatives may directly share) and may from time to time hold interests in the securities referred to in this document. The analyst TS Lim owns 200 shares in ANZ. ANALYST CERTIFICATION Each research analyst primarily responsible for the content of this research report, in whole or in part, certifies that with respect to each security or issuer that the analyst covered in this report: (1) all of the views expressed accurately reflect his or her personal views about those securities or issuers and were prepared in an independent manner and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by that research analyst in the research report. Page 12

ANZ Bank (ANZ) Unquestionably strong 1Q17. Healthy Jaws, safe to go back in the water SOURCE: BELL POTTER SECURITIES ESTIMATES

ANZ Bank (ANZ) Unquestionably strong 1Q17. Healthy Jaws, safe to go back in the water SOURCE: BELL POTTER SECURITIES ESTIMATES 17 February 2017 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 ANZ Bank (ANZ) Unquestionably strong 1Q17 Recommendation Buy (Hold) Price $30.21 Target (12 months) $33.25 (previously

More information

Perpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions

Perpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions 16 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation TS Lim 612 8224 2810 Perpetual (PPT) Oversold, upgrade to Buy Recommendation Buy (Hold) Price $42.09 Target (12 months) $47.50 (previously

More information

Platinum Asset Management (PTM)

Platinum Asset Management (PTM) 24 February 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 Recommendation Hold (unchanged) Price $5.10 Target (12 months) $4.90

More information

Auswide Bank (ABA) There are no tricks in plain and simple faith. 24 August : Underlying NPAT $17m, final dividend 18cps

Auswide Bank (ABA) There are no tricks in plain and simple faith. 24 August : Underlying NPAT $17m, final dividend 18cps 24 August 2018 TS Lim 612 8224 2810 Authorisation Tim Piper 612 8224 2825 Recommendation Buy (unchanged) Price $5.71 Target (12 months) $6.20 (previously $5.80) GICS Sector Banks Expected Return Capital

More information

Commonwealth Bank (CBA)

Commonwealth Bank (CBA) 10 February 2016 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Commonwealth Bank (CBA) Ordeal and triumph Recommendation Buy (unchanged) Price $74.20 Target (12 months) $83.50 (previously

More information

Adacel Technologies (ADA)

Adacel Technologies (ADA) 9 November 2018 Chris Savage 612 8224 2835 Authorisation TS Lim 612 8224 2810 Adacel Technologies (ADA) Bad, but not that bad Recommendation Buy (unchanged) Price $0.88 Target (12 months) $1.50 (previously

More information

National Australia Bank (NAB)

National Australia Bank (NAB) 6 February 2017 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $30.39 Target (12 months) $32.50 (previously $30.00) Expected Return Capital growth

More information

OneVue Holdings (OVH)

OneVue Holdings (OVH) 24 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation Peter Arden 613 9235 1833 OneVue Holdings (OVH) Restructured and focused Recommendation Buy (unchanged) Price $0.745 Target (12 months)

More information

OneVue Holdings (OVH)

OneVue Holdings (OVH) 7 August 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 OneVue Holdings (OVH) FY17 result to show cost-out progress Recommendation

More information

BWX Limited (BWX) SOURCE: BELL POTTER SECURITIES ESTIMATES

BWX Limited (BWX) SOURCE: BELL POTTER SECURITIES ESTIMATES 9 February 2017 Analyst John O'Shea 613 9235 1633 Authorisation John Hester 612 8224 2871 Recommendation Buy (unchanged) Price $4.80 Target (12 months) $5.73 (unchanged) Expected Return Capital growth

More information

Nanosonics (NAN) Preparing for new international markets. Maintain Hold, price target amended to $3.20 SOURCE: BELL POTTER SECURITIES ESTIMATES

Nanosonics (NAN) Preparing for new international markets. Maintain Hold, price target amended to $3.20 SOURCE: BELL POTTER SECURITIES ESTIMATES 21 February 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Nanosonics (NAN) Growth Slowly Emerging In Europe Recommendation Hold (unchanged) Price $2.80 Target (12 months) $3.20

More information

National Australia Bank (NAB)

National Australia Bank (NAB) 29 March 2016 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $25.62 Target (12 months) $29.50 (unchanged) Expected Return Capital growth 15.1%

More information

Challenger (CGF) Expanding the potential. A broader and more robust business emerging. Earnings revisions SOURCE: BELL POTTER SECURITIES ESTIMATES

Challenger (CGF) Expanding the potential. A broader and more robust business emerging. Earnings revisions SOURCE: BELL POTTER SECURITIES ESTIMATES 14 February 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 Challenger (CGF) Expanding the potential Recommendation Buy (unchanged)

More information

Mayne Pharma (MYX) Yet Another Transformational Acquisition. FY16 Earnings Confirmed. The company did not provide guidance in respect of FY17.

Mayne Pharma (MYX) Yet Another Transformational Acquisition. FY16 Earnings Confirmed. The company did not provide guidance in respect of FY17. 29 June 2016 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Mayne Pharma (MYX) Merger Fallout Creates Opportunity Recommendation Buy (unchanged) Price $1.485 Target (12 months) $1.89

More information

Nanosonics (NAN) Summary of 2Q17 Cash Flows SOURCE: BELL POTTER SECURITIES ESTIMATES

Nanosonics (NAN) Summary of 2Q17 Cash Flows SOURCE: BELL POTTER SECURITIES ESTIMATES 16 January 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Nanosonics (NAN) US Market Continues To Expand Recommendation Hold (unchanged) Price $3.16 Target (12 months) $3.28

More information

Cyclopharm (CYC) Entry to US market inching closer. Maintain Buy Recommendation SOURCE: BELL POTTER SECURITIES ESTIMATES

Cyclopharm (CYC) Entry to US market inching closer. Maintain Buy Recommendation SOURCE: BELL POTTER SECURITIES ESTIMATES Analyst John Hester 612 8224 2871 Cyclopharm (CYC) 5 March 2018 Speculative See key risks on Page 4 and Biotechnology Risk Warning on Page 7. Speculative securities may not be suitable for Retail Clients.

More information

SurfStitch (SRF) Shaping the Surf industry. Acquisition in Product drives credibility. however we have some concerns

SurfStitch (SRF) Shaping the Surf industry. Acquisition in Product drives credibility. however we have some concerns 26 November 20 Analyst Sam Byrnes 612 8224 2886 Authorisation Chris Savage 612 8224 2835 SurfStitch (SRF) Shaping the Surf industry Recommendation Buy (unchanged) Price $2.06 Target (12 months) $2.65 (previously

More information

Fortescue Metals Group Ltd (FMG)

Fortescue Metals Group Ltd (FMG) 3 March 2017 Analyst David Coates 612 8224 2887 Authorisation Peter Arden 613 9235 1833 Fortescue Metals Group Ltd (FMG) All about the iron ore price Recommendation Sell (unchanged) Price $6.62 Target

More information

Osprey (OSP) FY16 EBITDA Loss In Line. OSP has US$21.8m of cash as at 31 December Maintain Buy Rating And Valuation at $0.55

Osprey (OSP) FY16 EBITDA Loss In Line. OSP has US$21.8m of cash as at 31 December Maintain Buy Rating And Valuation at $0.55 27 February 2017 Analyst John Hester 612 8224 2871 Authorisation Tanushree Jain 612 8224 2849 Recommendation Buy (unchanged) Price $0.415 Valuation $0.55 (unchanged) Risk Speculative GICS Sector Healthcare

More information

Aeon Metals Limited (AML)

Aeon Metals Limited (AML) Analyst David Coates 612 8224 2887 Authorisation Stuart Howe 613 9235 1856 Speculative See key risks on Page 4 Speculative securities may not be suitable for retail clients 22 March 2019 Aeon Metals Limited

More information

Premier Investments (PMV)

Premier Investments (PMV) 16 March 2018 Analyst Sam Haddad 612 8224 2819 Authorisation Tim Piper 612 8224 2825 Premier Investments (PMV) Key growth pillars all strong Recommendation Buy (unchanged) Price $15.27 Target (12 months)

More information

IPH Limited (IPH) Buy at the bottom

IPH Limited (IPH) Buy at the bottom 29 March 2017 Analyst Sam Haddad 612 8224 2819 Authorisation TS Lim 612 8224 2810 IPH Limited (IPH) Buy at the bottom Recommendation Buy (unchanged) Price $4.76 Target (12 months) $7.90 (unchanged) Expected

More information

Westgold Resources (WGX)

Westgold Resources (WGX) 3 September 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $1.36 Target (12 months) $2.15 (unchanged) Expected Return Capital growth

More information

Breaker Resources NL (BRB)

Breaker Resources NL (BRB) David Coates 612 8224 2887 Authorisation Peter Arden 613 9235 1833 Speculative See key risks on Page 6. Speculative securities may not be suitable for retail clients 8 February 2019 Breaker NL (BRB) More

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 16 July 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.655 Target (12 months) $0.95 (previously $0.98) Expected Return Capital growth

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 5 September 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.515 Target (12 months) $0.90 (previously $0.95) Expected Return Capital

More information

Osprey Medical (OSP)

Osprey Medical (OSP) 18 October 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Osprey Medical (OSP) Harvey and Irma Curtail Growth Speculative See key risks on Page 5 and Biotechnology Risk Warning

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 19 April 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.76 Target (12 months) $0.98 (previously $1.00) Expected Return Capital growth

More information

Bank Note$ Mentioned in despatches. 7 March December 2017 reporting wrap: Fundamentals sound

Bank Note$ Mentioned in despatches. 7 March December 2017 reporting wrap: Fundamentals sound 7 March 2018 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Bank Note$ Mentioned in despatches Stock Price Target Rating ANZ $28.58 $32.50 Buy CBA $75.69 $83.90 Buy NAB $30.10 $34.20

More information

7.0% fully franked yield (expected 10.0% gross): Fixed until Nov 2018 reset date

7.0% fully franked yield (expected 10.0% gross): Fixed until Nov 2018 reset date 6 July 2012 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 William Spraggett 613 9235 1733 Whitefield Resettable Preference Shares (WHFPB) Authorisation John Gleeson 612 9255 7220

More information

ANZ Bank. What execution risk? Earnings and target price revision. Price catalyst. Catalyst: 1Q17 Trading update, February 2017.

ANZ Bank. What execution risk? Earnings and target price revision. Price catalyst. Catalyst: 1Q17 Trading update, February 2017. AUSTRALIA ANZ AU Price (at 09:15, 18 Jan 2017 GMT) Neutral A$30.11 Valuation A$ 30.69- - Sum of Parts/GG 31.47 12-month target A$ 31.00 12-month TSR % +8.4 Volatility Index Low/Medium GICS sector Banks

More information

Galaxy Resources Ltd (GXY)

Galaxy Resources Ltd (GXY) Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Recommendation Buy (unchanged) Price $1.835 Valuation $3.35 (unchanged) -------------- Risk Speculative Expected Return Capital

More information

Peet Bonds (PPCHA) A yield uplift from fixed rate senior debt

Peet Bonds (PPCHA) A yield uplift from fixed rate senior debt 4 May 2016 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 (PPCHA) Authorisation TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue ASX code Peet PPCHA Face value $100 Estimated

More information

Galaxy Resources Ltd (GXY)

Galaxy Resources Ltd (GXY) 27 March 2018 Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Galaxy Resources Ltd (GXY) Mt Cattlin doing what it is meant to Recommendation Buy Price $3.16 Price Target $4.75

More information

Breaker Resources NL (BRB)

Breaker Resources NL (BRB) Analyst David Coates 612 8224 2887 Authorisation Peter Arden 613 9235 1833 Recommendation Buy (unchanged) Price $0.315 Valuation $0.96 (previously $1.30) Risk Speculative GICS Sector Materials Expected

More information

Tech Sector. Updated key sells: None. Company Ticker Share price at Market Year end 22-Mar-17 cap FY17a/CY17e FY18e/CY18e FY17a/CY17e FY18e/CY18e

Tech Sector. Updated key sells: None. Company Ticker Share price at Market Year end 22-Mar-17 cap FY17a/CY17e FY18e/CY18e FY17a/CY17e FY18e/CY18e 22 March 2017 Analyst Chris Savage 612 8224 2835 Authorisation TS Lim 612 8224 2810 Tech Sector Key picks unchanged: IRI, APX, ADA & IFM Stock Price Target Rating ADA $2.37 $3.25 Buy ALU $7.41 $7.90 Hold

More information

Talisman Mining Ltd (TLM)

Talisman Mining Ltd (TLM) Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.41 Valuation $0.88 (previously $1.00) Risk Speculative Expected Return Capital growth

More information

National Australia Bank

National Australia Bank AUSTRALIA NAB AU Price (at 08:23, 03 Jul 2012 GMT) Outperform A$23.68 Volatility index Low 12-month target A$ 27.66 12-month TSR % +24.9 Valuation A$ - DCF (WACC 12.6%, beta 1.0, ERP 5.0%, RFR 5.8%) 25.14

More information

Bendigo and Adelaide Bank

Bendigo and Adelaide Bank AUSTRALIA BEN AU Price (at CLOSE#, 17 Aug 2012) Neutral A$8.69 Volatility index Low 12-month target A$ 9.28 12-month TSR % +14.0 Valuation - DCF (WACC 12.1%) A$ 8.28 GICS sector Banks Market cap A$m 3,447

More information

ANZ Capital Notes Offer

ANZ Capital Notes Offer ANZ Capital Notes Offer AUSTRALIA AND NEW ZEALAND BANKING GROUP LIMITED 2 July 2013 Disclaimer Australia and New Zealand Banking Group Limited (ABN 11 005 357 522) ("ANZ") is the issuer of the ANZ Capital

More information

Westpac 2009 Full Year Results

Westpac 2009 Full Year Results Westpac 2009 Full Year Results Gail Kelly Chief Executive Officer Westpac Banking Corporation ABN 33 007 457 141 Key areas of focus in 2009 Position the Group strongly through the GFC and economic downturn

More information

Australian Banks. Pre-Reporting Form Guide AUSTRALIA. Event. Impact. Outlook

Australian Banks. Pre-Reporting Form Guide AUSTRALIA. Event. Impact. Outlook AUSTRALIA MRE vs Consensus MQG FY15 Consensus FY15 Date Profit EPS DPS Profit EPS DPS BEN 10-Aug 439 92 67 434 92 67 CBA 12-Aug 9,289 557 420 9,116 554 419 Source: Factset, Macquarie Research, August 2015

More information

ANZ Bank. Turning the corner? Earnings and target price revision. Price catalyst. Catalyst: 1Q17 Trading update, February 2017.

ANZ Bank. Turning the corner? Earnings and target price revision. Price catalyst. Catalyst: 1Q17 Trading update, February 2017. AUSTRALIA ANZ AU Price (at 11:16, 3 Nov 216 GMT) Outperform A$27.35 Valuation A$ 27.47- - Sum of Parts/GG 29.23 12-month target A$ 28.5 12-month TSR +1.2 Volatility Index Low/Medium GICS sector Banks Market

More information

AMP. Earnings and target price revision. No change. Price catalyst. Action and recommendation

AMP. Earnings and target price revision. No change. Price catalyst. Action and recommendation AUSTRALIA AU Price (at CLOSE#, 19 Mar 213) Underperform A$5.7 Volatility index Low 12-month target A$ 4.99 12-month TSR % +3.6 Valuation - Sum of Parts A$ 4.68 GICS sector Insurance Market cap A$m 14,855

More information

St George Mining Ltd (SGQ)

St George Mining Ltd (SGQ) Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Recommendation Buy (unchanged) Price $0.225 Valuation $0.30 (previously $0.26) Risk Speculative Expected Return Capital growth

More information

Macquarie Group Capital Notes 2 (MQGPB) * MANDATORY CONVERSION IS SUBJECT TO SATISFYING THE MANDATORY CONVERSION CONDITIONS

Macquarie Group Capital Notes 2 (MQGPB) * MANDATORY CONVERSION IS SUBJECT TO SATISFYING THE MANDATORY CONVERSION CONDITIONS 23 November 2015 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation Macquarie Group Capital Notes 2 (MQGPB) TS Lim 612 8224 2810 Fixed Interest Issue overview Issuer Issue

More information

Australia and New Zealand Banking Group Limited

Australia and New Zealand Banking Group Limited Australia and New Zealand Banking Group Limited ABN 11 005 357 522 31 March 2017 Consolidated Financial Report Dividend Announcement and Appendix 4D The Consolidated Financial Report and Dividend Announcement

More information

Fortescue Metals Group (FMG)

Fortescue Metals Group (FMG) 30 October 2015 Analyst David Coates 612 8224 2887 Authorisation John Hester 612 8224 2871 Recommendation Buy (Hold) Price $2.09 Target (12 months) $2.40 (unchanged) Expected Return Capital growth 14.8%

More information

At a glance...5. Executive summary...6. Net Interest Income Asset Quality Non-interest income Capital Costs...

At a glance...5. Executive summary...6. Net Interest Income Asset Quality Non-interest income Capital Costs... At a glance...5 Executive summary...6 Net Interest Income... 10 Asset Quality... 13 Non-interest income... 15 Capital... 17 Costs... 19 Return on Equity... 21 Major Australian Banks: Half Year 2018 Results

More information

Australian Banks. Funding markets open for now

Australian Banks. Funding markets open for now AUSTRALIA Weekly performance 4% 2% % -2% -4% -6% -8% -1% Source: IRESS, August 212 Rolling monthly performance 8% 6% 4% 2% % -2% -4% -6% Source: IRESS, August 212 Rolling yearly performance % 15% 5% -5%

More information

Earnings and target price revision. Price catalyst. Catalyst: 1H14 result in February Action and recommendation

Earnings and target price revision. Price catalyst. Catalyst: 1H14 result in February Action and recommendation AUSTRALIA CBA AU Price (at 06:10, 10 Sep 2013 GMT) Neutral A$73.63 Valuation A$ - DCF (WACC 10.3%, beta 1.0, ERP 5.0%, RFR 5.5%) 50.40 12-month target A$ 66.15 12-month TSR % -5.0 Volatility Index Low

More information

Platinum Asset Management

Platinum Asset Management AUSTRALIA PTM AU Price (at 06:10, 11 Jul 2016 GMT) Neutral A$5.52 Valuation A$ - DCF (WACC 9.3%, beta 1.2, ERP 5.0%, RFR 3.3%) 5.19 12-month target A$ 5.36 12-month TSR % +2.6 Volatility Index Low/Medium

More information

MARKETS ISSUANCE PROGRAMME Relating to Notes, Certificates and Warrants

MARKETS ISSUANCE PROGRAMME Relating to Notes, Certificates and Warrants SUPPLEMENTARY PROSPECTUS DATED 17 February 2017 Australia and New Zealand Banking Group Limited Australian Business Number 11 005 357 522 (Incorporated with limited liability in Australia) MARKETS ISSUANCE

More information

Mesoblast (MSB) GVHD granted Fast Track, should benefit ongoing negotiations with Mallinckrodt

Mesoblast (MSB) GVHD granted Fast Track, should benefit ongoing negotiations with Mallinckrodt 7 March 2017 Analyst Tanushree Jain 612 8224 2849 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $1.90 Valuation $3.22 (previously $3.17) Risk Speculative GICS Sector Pharmaceuticals

More information

Premier Investments (PMV)

Premier Investments (PMV) 4 April 2017 Analyst Sam Haddad 612 8224 2819 Authorisation TS Lim 612 8224 2810 Premier Investments (PMV) The Myers touch Recommendation Buy (unchanged) Price $14.20 Target (12 months) $17.65 (previously

More information

Westgold Resources (WGX)

Westgold Resources (WGX) 7 February 2017 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $2.25 Target (12 months) $2.60 Expected Return Capital growth 15.6% Dividend

More information

1H19 RESULTS PRESENTATION

1H19 RESULTS PRESENTATION 1H19 RESULTS PRESENTATION 11 APRIL 2019 Half year ended 28 February 2019 Anthony Rose Interim CEO Matt Baxby Chief Financial Officer Anthony Rose Interim CEO 2 Niche growth, asset quality and capital remain

More information

NAB 2015 Half Year Results

NAB 2015 Half Year Results 800 Bourke Street Docklands VIC 3008 AUSTRALIA www.nabgroup.com Thursday, 7 May 2015 ASX Announcement NAB 2015 Half Year Results Executing our strategy, building a stronger bank Highlights Cash earnings

More information

BUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS

BUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS BUY 0.11 0.39 0.69 SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS CONTENTS Competitors Products Sales channels Pricing Model INVESTMENT THESIS COMPANY OVERVIEW INDUSTRY OVERVIEW COMPETITORS BOARD

More information

Ride the recovery. Figure 1: Trading margins on debt and equity securities. (prior to exchange) over BBSW Mand Conv* Call

Ride the recovery. Figure 1: Trading margins on debt and equity securities. (prior to exchange) over BBSW Mand Conv* Call 17 May 2016 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue ASX code BELL POTTER SECURITIES LIMITED ACN

More information

Challenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation

Challenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation 1H13E 2H13E 1H14E 2H14E 1H15E 2H15E AUSTRALIA CGF AU Price (at CLOSE#, 20 Aug 2012) Outperform A$3.76 Volatility index Low 12-month target A$ 4.57 12-month TSR % +26.4 Valuation - Sum of Parts A$ 4.57

More information

Australia and New Zealand Banking Group Limited

Australia and New Zealand Banking Group Limited Australia and New Zealand Banking Group Limited ABN 11 005 357 522 Full Year 30 September 2017 Consolidated Financial Report Dividend Announcement and Appendix 4E The Consolidated Financial Report and

More information

Profit Announcement For the full year ended 30 June 2013

Profit Announcement For the full year ended 30 June 2013 Profit Announcement For the full year ended 30 June 2013 COMMONWEALTH BANK OF AUSTRALIA ACN 123 123 124 14 AUGUST 2013 FIND OUT MORE VIA OUR APP ASX Appendix 4E Results for announcement to the market (1)

More information

PILLAR 3 DISCLOSURE APS 330: PUBLIC DISCLOSURE

PILLAR 3 DISCLOSURE APS 330: PUBLIC DISCLOSURE 2017 BASEL III PILLAR 3 DISCLOSURE AS AT 31 DECEMBER 2017 APS 330: PUBLIC DISCLOSURE Important notice This document has been prepared by Australia and New Zealand Banking Group Limited (ANZ) to meet its

More information

QBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision

QBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision AUSTRALIA QBE AU Price (at 10:44, 27 Apr 2016 GMT) Neutral A$11.19 Valuation A$ - DCF (WACC 9.3%, beta 1.1, ERP 5.0%, RFR 3.8%) 11.34 12-month target A$ 12.00 12-month TSR % +12.7 Volatility Index Low/Medium

More information

Australian Banks. If it s too good to be true AUSTRALIA. Event. Impact. Outlook. Impact of repricing and capital from additional 10% investor RWA

Australian Banks. If it s too good to be true AUSTRALIA. Event. Impact. Outlook. Impact of repricing and capital from additional 10% investor RWA CBA CBA CBA CBA AUSTRALIA Changes to lending rates (bps) bps Owner Occupier Investor P&I IO P&I IO 0 20 25 36 CBA 3 25 24 26 7 7 25 25 3 8 23 28 BEN 0 0 25 25 Source: Company data, Macquarie research,

More information

Profit Announcement. For the full year ended 30 June 2017

Profit Announcement. For the full year ended 30 June 2017 Profit Announcement For the full year ended 30 June 2017 Commonwealth Bank of Australia ACN 123 123 124 9 August 2017 ASX Appendix 4E Results for announcement to the market (1) Report for the year ended

More information

Value at the top end. Figure 1: Trading margins on debt and equity securities

Value at the top end. Figure 1: Trading margins on debt and equity securities 17 February 2012 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation Steve Goldberg 612 8224 2809 Westpac Convertible Preference Shares (WBCPC) Fixed Interest Issue overview

More information

Australian Banks. Insolent Insolvencies

Australian Banks. Insolent Insolvencies AUSTRALIA Insolvencies Stubborn # of Insolvencies 17, 16, 15, 14, 13, 12, 11, 1, Source: ASIC, Macquarie Research, Dec 212 WA/VIC insolvencies deterioration 2.4 2.2 Jan- 2 1.8 1.6 1.4 1.2 1 Source: ASIC,

More information

Consolidated Operations Group (COG)

Consolidated Operations Group (COG) Consolidated Operations Group (COG) 10 April 2018 Outperform Upgrade to OUTPERFORM - Inflection point nearing $0.10 Jason Palmer jpalmer@taylorcollison.com.au +618 8217 3965 Summary (AUD) Market Capitalisation

More information

National Australia Bank

National Australia Bank AUSTRALIA NAB AU Price (at 06:10, 27 Jul 2015 GMT) Outperform A$33.91 Valuation A$ - DCF (WACC 9.6%, beta 1.0, ERP 5.0%, RFR 5.8%) 37.74 12-month target A$ 39.39 12-month TSR % +22.1 Volatility Index Low

More information

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation AUSTRALIA BLY AU Price (at 08:01, 12 Sep 2013 GMT) Neutral A$0.50 Valuation A$ 0.71 - DCF (WACC 10.1%, beta 1.5, ERP 0.1%, RFR 0.1%, TGR 0.0%) 12-month target A$ 0.56 12-month TSR % +12.0 Volatility Index

More information

Financial results. Half year ended 31 December Nick Hawkins Chief Financial Officer. Peter Harmer Managing Director and Chief Executive Officer

Financial results. Half year ended 31 December Nick Hawkins Chief Financial Officer. Peter Harmer Managing Director and Chief Executive Officer Financial results Half year ended 31 December 2017 Peter Harmer Managing Director and Chief Executive Officer Nick Hawkins Chief Financial Officer 14 February 2018 Overview Peter Harmer Managing Director

More information

Australian Banks. Money Talks vertically challenged AUSTRALIA. Inside. Majors average short positions and banks index

Australian Banks. Money Talks vertically challenged AUSTRALIA. Inside. Majors average short positions and banks index Jun- Dec- Jun- Dec- Jun- Dec- Jun-1 Dec-1 Jun-11 Dec-11 Jun-1 Dec-1 Jun-1 Dec-1 Jun-1 Dec-1 Jun- Dec- AUSTRALIA Repricing generally follows an election s Nov Aug 1 Sep 1 1-1 Source: RBA, Macquarie Research,

More information

Fund Managers. Aust. Fund managers review & rank AUSTRALIA. Event. Stock Views

Fund Managers. Aust. Fund managers review & rank AUSTRALIA. Event. Stock Views AUSTRALIA 4 February 2016 Macquarie Securities (Australia) Limited Aust. Fund managers review & rank Event We review and rank the listed Australian under Macquarie Securities coverage, assessing fund performance,

More information

BASEL III PILLAR 3 DISCLOSURE

BASEL III PILLAR 3 DISCLOSURE BASEL III PILLAR 3 DISCLOSURE AS AT 31 DECEMBER 20 DECEMBER 20 PILLAR 3 / 2018 FIRST QUARTER CHART PACK AUSTRALIA AND NEW Z EALAND BANKING GROUP LIMITED 20 FEBRUARY 2018 To be read in conjunction with

More information

Aust. General Insurance

Aust. General Insurance AUSTRALIA June 2016 3 mth rolling market results Personal Commercial Market Average Rate Growth -3. -3.6% -3.3% GWP Growth 1.8% -0.8% 0.9% Volume Growth 2.8% 0.8% 2.1% Est. Exposure Value Growth 2. 2.

More information

Generation Healthcare REIT

Generation Healthcare REIT AUSTRALIA GHC AU Price (at 06:13, 24 Aug 2015 GMT) Neutral A$1.65 Valuation - Sum of Parts A$ 1.51-1.59 12-month target A$ 1.59 12-month TSR % +1.8 Volatility Index Low GICS sector Real Estate Market cap

More information

Figure 1: ASX listed debt redemptions Figure 2: Trading margins on debt and equity securities

Figure 1: ASX listed debt redemptions Figure 2: Trading margins on debt and equity securities 8 February 2017 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation (NABPE) TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue ASX code NAB NABPE Face value $100

More information

Bank of Queensland Capital Notes (BOQPE) Figure 1: Trading margins on debt and equity securities. (prior to exchange) over BBSW Mand Conv* Call

Bank of Queensland Capital Notes (BOQPE) Figure 1: Trading margins on debt and equity securities. (prior to exchange) over BBSW Mand Conv* Call 23 November 2017 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation Bank of Queensland Capital Notes (BOQPE) TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue

More information

ANZ Bank. The Dis-Associates. Earnings and target price revision. No change. Price catalyst. Catalyst: 3Q15 Trading Update. Action and recommendation

ANZ Bank. The Dis-Associates. Earnings and target price revision. No change. Price catalyst. Catalyst: 3Q15 Trading Update. Action and recommendation AUSTRALIA ANZ AU Price (at 07:51, 03 Jul 2015 GMT) Underperform A$32.46 Valuation - DDM/PE A$ 32.52 12-month target A$ 33.91 12-month TSR % +10.0 Volatility Index Low GICS sector Banks Market cap A$m 89,752

More information

2001 Investor Roadshow Presentation 12 November

2001 Investor Roadshow Presentation 12 November 2001 Investor Roadshow Presentation 12 November 2001 www.commbank.com.au Disclaimer The material that follows is a presentation of general background information about the Bank s activities current at

More information

ANZ Bank. Trimming the fat A$23.06 AUSTRALIA. Focus on returns should yield value. Elevated historical cost growth provides opportunity

ANZ Bank. Trimming the fat A$23.06 AUSTRALIA. Focus on returns should yield value. Elevated historical cost growth provides opportunity AUSTRALIA ANZ AU Price (at 08:39, 07 Jul 2016 GMT) Outperform A$23.06 Valuation A$ 25.81- - Sum of Parts/GG 30.76 12-month target A$ 28.00 12-month TSR +28.6 Volatility Index Low GICS sector Banks Market

More information

Financial results. Full year ended 30 June Nick Hawkins Chief Financial Officer. Peter Harmer Managing Director and Chief Executive Officer

Financial results. Full year ended 30 June Nick Hawkins Chief Financial Officer. Peter Harmer Managing Director and Chief Executive Officer Financial results Full year ended 30 June 2017 Peter Harmer Managing Director and Chief Executive Officer Nick Hawkins Chief Financial Officer 23 August 2017 Overview Peter Harmer Managing Director and

More information

TABLE OF CONTENTS Interim Profit Announcement 2005

TABLE OF CONTENTS Interim Profit Announcement 2005 Profit Announcement For the six months ended 3 March 2005 This interim profit announcement has been prepared for distribution in the United States of America TABLE OF CONTENTS Interim Profit Announcement

More information

Paragon Care (PGC) Big Boxes, Big Opportunity. Capitalising on the burgeoning healthcare sector. Price leadership through quality

Paragon Care (PGC) Big Boxes, Big Opportunity. Capitalising on the burgeoning healthcare sector. Price leadership through quality 26 September 2014 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Paragon Care (PGC) Big Boxes, Big Opportunity Recommendation Buy (Initiation) Price $0.33 Target (12 months) $0.38

More information

For personal use only

For personal use only NAB 2017 Full Year Results Summary Sarah and Justin Montesalvo Patriot Campers 2017 FINANCIAL HIGHLIGHTS $ 5,285 M Statutory net profit 99 CPS Final dividend 100% franked $ 5.3 BN Dividends declared $

More information

COMMONWEALTH BANK OF AUSTRALIA DELIVERS CASH EARNINGS GROWTH OF 8 PER CENT FOR FIRST HALF Highlights of the 2015 Interim Result

COMMONWEALTH BANK OF AUSTRALIA DELIVERS CASH EARNINGS GROWTH OF 8 PER CENT FOR FIRST HALF Highlights of the 2015 Interim Result COMMONWEALTH BANK OF AUSTRALIA DELIVERS CASH EARNINGS GROWTH OF 8 PER CENT FOR FIRST HALF 2015 Highlights of the 2015 Interim Result Statutory NPAT of $4,535 million up 8 per cent; (1,2,3) Cash NPAT of

More information

For personal use only

For personal use only For personal use only Profit Announcement FOR THE FULL YEAR ENDED 30 JUNE 2014 COMMONWEALTH BANK OF AUSTRALIA ACN 123 123 124 13 AUGUST 2014 ASX Appendix 4E Results for announcement to the market (1) Report

More information

HALF YEAR RESULTS 2017

HALF YEAR RESULTS 2017 HALF YEAR RESULTS Incorporating the requirements of Appendix 4D The half year results announcement incorporates the half year report given to the Australian Securities Exchange (ASX) under Listing Rule

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 1 November 2016 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $1.38 Target (12 months) $2.10 (unchanged) Expected Return Capital growth

More information

UBS Investment Research Brambles Limited

UBS Investment Research Brambles Limited UBS Investment Research Brambles Limited FY12 result: strong revenue momentum Result highlights strong revenue momentum Brambles FY12 result was slightly ahead of expectations, revealing 11% underlying

More information

Media Release CBA 1H17 Results

Media Release CBA 1H17 Results Media Release CBA 1H17 Results For the half year ended 31 December 2016¹ Reported 15 February 2017 Summary Statutory net profit after tax (NPAT) of $4,895 million, up 6%. 2 Cash NPAT of $4,907 million,

More information

For personal use only

For personal use only Media Release CBA FY17 Results For the full year ended 30 June 2017¹ Reported 9 August 2017 Commonwealth Bank delivers for Australia CEO Comment: Ian Narev Commonwealth Bank s performance this year has

More information

SG Fleet Group. Another UK acquisition. Earnings and target price revision

SG Fleet Group. Another UK acquisition. Earnings and target price revision AUSTRALIA SGF AU Price (at 08:26, 30 Nov 2016 GMT) Outperform A$3.23 Valuation - PER A$ 3.96-4.22 12-month target A$ 4.37 12-month TSR % +41.0 Volatility Index High GICS sector Commercial & Professional

More information

Strike Energy Ltd (STX)

Strike Energy Ltd (STX) Analyst Peter Arden 613 9235 1833 Authorisation Stuart Howe 613 9235 1782 Recommendation Buy (unchanged) Price $0.115 Valuation $0.26 (previously $0.23) Risk Speculative Expected Return Capital growth

More information

Sigma Insight Capital Hungry Banks

Sigma Insight Capital Hungry Banks June 2015 Sigma Insight Capital Hungry Banks Summary Major Bank capital builds of approx. $40-$60bn to see EPS and DPS track sideways Rising capital intensity to place downward pressure on ROE s Payout

More information

Australia and New Zealand Banking Group Limited

Australia and New Zealand Banking Group Limited Australia and New Zealand Banking Group Limited ABN 11 005 357 522 Half Year 31 March 2018 Consolidated Financial Report Dividend Announcement and Appendix 4D The Consolidated Financial Report and Dividend

More information

Media Presentation. Results Presentation FOR THE FULL YEAR ENDED 30 JUNE Ian Narev Chief Executive Officer. 10 February 2010

Media Presentation. Results Presentation FOR THE FULL YEAR ENDED 30 JUNE Ian Narev Chief Executive Officer. 10 February 2010 Media Presentation FOR THE FULL YEAR ENDED 30 JUNE 2012 Results Presentation Ian Narev Chief Executive Officer For the half year ended 31 December 2009 10 February 2010 Commonwealth Bank of Australia ACN

More information

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016. AUSTRALIA IFL AU Price (at 06:35, 26 Oct 2016 GMT) Outperform A$8.34 Valuation A$ - DCF (WACC 8.8%, beta 1.1, ERP 5.0%, RFR 3.3%) 8.74 12-month target A$ 9.00 12-month TSR % +14.3 Volatility Index Low/Medium

More information